Studies have shown that proteasome subunit beta 5 (PSMB5) is overexpressed in triple-negative breast cancer and significantly associated with a poor prognosis 36 and that knockdown of PSMB5 gene expression inhibits MDA-MB-231 cell growth and migration 37. Here, PSMB5 is linked to triple-negative breast carcinoma.